News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SkinMedica, Inc. Files Patent and Trade Secret Action Against Histogen, Inc.


1/22/2009 11:21:39 PM

SAN DIEGO--(BUSINESS WIRE)--SkinMedica®, Inc. announced that it has initiated a patent and trade secret action against Histogen, Inc., Histogen Aesthetics, LLC and Dr. Gail Naughton, founder, President and Chief Executive Officer of Histogen and Histogen Aesthetics. Dr. Naughton was a co-founder of Advanced Tissue Sciences or ATS, which initiated bankruptcy proceedings in 2002. SkinMedica acquired several assets from ATS, including intellectual property encompassing its NouriCel® technology. The complaint seeks damages and an injunction against the defendants for the development and manufacture of aesthetic and therapeutic products using SkinMedica’s patented conditioned cell culture media technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES